ANNE DE GROOT, M.D.
Osteopathic Medicine at Summit Ave, Providence, RI
License number
Rhode Island 8278
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
164 Summit Ave, Providence, RI 02906
Phone
(401) 793-2427
(401) 952-4227
(401) 952-4227
Organization information
See more information about ANNE DE GROOT at bizstanding.comAnne De Groot MD
146 Clifford St, Providence, RI 02903
Industry:
Internist
Phone:
(401) 272-2123 (Phone)
Anne Searls De Groot
Professional information
Dr. Anne Groot, Providence RI - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
MIRIAM HOSPITAL
164 Summit Ave, Providence 02906
(401) 793-2500 (Phone), (401) 793-4679 (Fax)
Rise Clinic
14 3Rd St, Providence 02906
(401) 793-2427 (Phone)
MIRIAM HOSPITAL
164 Summit Ave, Providence 02906
(401) 793-2500 (Phone), (401) 793-4312 (Fax)
164 Summit Ave, Providence 02906
(401) 793-2500 (Phone), (401) 793-4679 (Fax)
Rise Clinic
14 3Rd St, Providence 02906
(401) 793-2427 (Phone)
MIRIAM HOSPITAL
164 Summit Ave, Providence 02906
(401) 793-2500 (Phone), (401) 793-4312 (Fax)
Certifications:
Infectious Disease, 1992, Internal Medicine, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
MIRIAM HOSPITAL
164 Summit Ave, Providence 02906
Rise Clinic
14 3Rd St, Providence 02906
MIRIAM HOSPITAL
164 Summit Ave, Providence 02906
Rhode Island Hospital
593 Eddy St, Providence 02903
164 Summit Ave, Providence 02906
Rise Clinic
14 3Rd St, Providence 02906
MIRIAM HOSPITAL
164 Summit Ave, Providence 02906
Rhode Island Hospital
593 Eddy St, Providence 02903
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1983
Beth Israel Deaconess Medical Center
Natl Inst Hlth
New England Mc
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1983
Beth Israel Deaconess Medical Center
Natl Inst Hlth
New England Mc
Anne Searls De Groot, Providence RI
Specialties:
Internal Medicine, Infectious Disease
Work:
Epivax, Inc.
146 Clifford St, Providence, RI 02903
146 Clifford St, Providence, RI 02903
Education:
University of Chicago (1983), Tufts University (1986) *Internal Medicine, National Institutes of Health (1989) *
Regulatory T Cell Epitopes, Compositions And Uses Thereof
US Patent:
2009001, Jan 15, 2009
Filed:
Jan 29, 2008
Appl. No.:
12/021832
Inventors:
Anne De Groot - Providence RI, US
William Martin - Cumberland RI, US
Daniel S. Rivera - Marshfield MA, US
William Martin - Cumberland RI, US
Daniel S. Rivera - Marshfield MA, US
International Classification:
A61K 38/00, C07K 14/00, C12N 15/11, A61P 37/00, C12N 15/00, C12N 5/06
US Classification:
514 12, 530350, 536 235, 4353201, 435325, 435378, 435375
Abstract:
The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
Regulatory T Cell Epitopes, Compositions And Uses Thereof
US Patent:
2011018, Jul 28, 2011
Filed:
Dec 29, 2010
Appl. No.:
12/981098
Inventors:
Anne DE GROOT - Providence RI, US
William Martin - Cumberland RI, US
Daniel S. Rivera - Marshfield MA, US
William Martin - Cumberland RI, US
Daniel S. Rivera - Marshfield MA, US
International Classification:
A61K 39/00, C07K 14/00, A61K 38/16, C12N 5/0783, A61P 37/08, A61P 37/02
US Classification:
4241851, 530326, 514 214, 435377, 530324, 514 213
Abstract:
The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
Human T Cell Response To Mhc-Binding Motif Clusters
US Patent:
2002011, Aug 29, 2002
Filed:
Mar 20, 2001
Appl. No.:
09/813333
Inventors:
Anne Groot - Providence RI, US
International Classification:
A01N037/18, A61K038/00, A61K031/70, A01N043/04, A61K039/00, A61K039/38, A61K039/02, A61K039/04
US Classification:
424/184100, 424/248100, 424/234100, 514/002000, 514/044000
Abstract:
The invention provides (Mtb) vaccine candidate peptides. The invention also provides a method for identifying Mtb vaccine candidate peptides as well as vaccines comprising these Mtb candidate peptides.
Hiv Vaccine Candidate Peptides
US Patent:
2002018, Dec 5, 2002
Filed:
Oct 26, 2001
Appl. No.:
10/055524
Inventors:
Anne Groot - Providence RI, US
International Classification:
A61K048/00, A61K039/21, A61K039/29, C12N009/22
US Classification:
424/188100, 435/199000, 514/044000
Abstract:
The invention provides HIV vaccine candidates that have “evolved” due to gene shuffling in vitro for inclusion of “cross-clade” characteristics. The invention also provides a method for identifying HIV vaccine candidates that could be presented in the context of more than one HLA, due to the creation of promiscuous epitopes by gene shuffling.
Methods Of Determining West Nile Virus Epitopes And Method Of Using The Same
US Patent:
2005004, Mar 3, 2005
Filed:
Feb 28, 2002
Appl. No.:
10/468950
Inventors:
Anne De Groot - Providence RI, US
William Martin - Cumberland RI, US
William Martin - Cumberland RI, US
International Classification:
C12Q001/70, A61K039/12
US Classification:
424186100, 435005000
Abstract:
Vaccines containing one or more West Nile Virus (WNV) vaccine candidate peptides in an immunologically acceptable excipient are disclosed. Also provided are recombinant WNV vaccine candidate peptides, wherein the peptide is expressed from a recombinant polynucleotide such as a naked DNA vaccine. Additionally, methods for inducing anti-WNV immune responses in a mammalian subject are also disclosed.
Human T Cell Response To Mhc-Binding Motif Clusters
US Patent:
2002019, Dec 19, 2002
Filed:
Nov 9, 2001
Appl. No.:
10/044703
Inventors:
Anne Groot - Providence RI, US
International Classification:
A61K039/02, A61K039/04
US Classification:
424/190100, 424/248100
Abstract:
The invention provides Mycobacterium tuberculosis (Mtb) vaccine candidate peptides. The invention also provides a method for identifying Mtb vaccine candidate peptides as well as vaccines comprising these Mtb candidate peptides.